AUSA News

January 17, 2020

Australis Capital Announces Change in Management

LAS VEGAS, NV, January 17, 2020 – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) announced that Mr. Michael Carlotti’s employment with the Company as Chief Financial Officer has been terminated effective January 16, 2020.
January 15, 2020

Tsunami™ and GT Flowers Unite To Take Top Prizes in Concentrates and Vape Cartridges at High Times Cannabis Cup Nevada 2019

LAS VEGAS, NV, January 15, 2020 – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) is pleased to announce that AUSA’s wholly-owned brands Tsunami™, a science-driven recreational extract brand, and GT Flowers,
January 7, 2020

Australis Capital Strengthens Leadership Team with Chief Accounting Officer Appointment

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) is pleased to announce that effective immediately, Alex Han, formerly Vice President of Accounting, has been promoted to Chief Accounting Officer.
December 17, 2019

Australis Capital Signs Agreement with RapidCash ATM

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) announces that it has finalized a vendor agreement with RapidCash ATM Ltd. for the purchase of retail kiosks to be used with AUSA’s Cocoon Technology solution, disclosed in AUSA’s press release dated October 29, 2019. For the kiosks, the Company will issue total consideration of 5 million shares of Body and Mind, Inc. common stock currently held by the Company to RapidCash ATM Ltd.
December 11, 2019

Australis Capital and Folium Biosciences Agree to Merger to Create a Publicly Held Vertically Integrated Producer of Non-Psychoactive Cannabinoids

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (the “Company” or “AUSA”) is pleased to announce it has entered into an agreement and plan of merger by and among AUSA, Folium Equity Holding LLC (“Folium”), and Folium Merger Sub, LLC, a newly formed and wholly-owned Colorado subsidiary of AUSA, (“Merger Sub”) pursuant to which AUSA will acquire (the “Proposed Transaction”) all of the outstanding Folium membership units not already owned by AUSA. The agreement was signed on December 10, 2019. The Proposed Transaction will be completed by way of a merger between Folium and Merger Sub, and Folium will become a wholly owned subsidiary of AUSA. AUSA will be rebranded as Folium Biosciences (the “Resulting Issuer”) prior to the Proposed Transaction and will carry on the current business of Folium.
December 9, 2019

Cocoon Technology Signs Exclusive Agreement with THRIVE Cannabis Marketplace, Nevada’s Largest Independent Dispensary Chain

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) is pleased to announce THRIVE Cannabis Marketplace (“THRIVE”) has entered into a four-year agreement with Cocoon Technology LLC (“Cocoon”), including CocoonPod™ and CocoonRewards™ the world’s most robust Platform-as-a-Service (PAAS) specifically developed for dispensaries. Through this agreement, Cocoon will become the exclusive self-service technology provider for THRIVE.
November 29, 2019

Australis Capital Appoints New Auditor

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) has appointed Squar Milner, LLP as its auditor. Squar Milner, LLP will replace MNP, LLP effective November 27, 2019.
October 29, 2019

Australis Capital Launches Cocoon Technology — A Self-Service Fulfillment Platform For Dispensaries and Highly Regulated Brick & Mortar Retailers

Australis Capital Inc. (CSE: AUSA OTC: AUSAF) (“AUSA” or the “Company”) is pleased to announce the formation of Cocoon Technology LLC (“Cocoon”), a cloud-based, self-service fulfillment platform and wholly-owned subsidiary of AUSA.
October 1, 2019

Australis Capital Achieves Milestone in Tropical Parkway Facility in Development in North Las Vegas

Australis Capital Inc. (CSE: AUSA OTC: AUSAF) (“AUSA” or the “Company”) is pleased to announce that AUSA has been granted a Special Use Permit by the city of North Las Vegas for the Tropical Parkway land acquired in the Green Therapeutics acquisition.